| Trial Identifier: | D6130C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02579226 |
| Start Date: | October 2015 |
| Primary Completion Date: | February 2020 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version |
| Country | Location |
|---|---|
| United States of America, CO | Denver, CO, United States of America, 80218 |
| United States of America, FL | Sarasota, FL, United States of America, 34232 |
| United States of America, MA | Boston, MA, United States of America, 02215 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
| United States of America, TX | Houston, TX, United States of America, 77030 |
| United States of America, WI | Milwaukee, WI, United States of America, 53226 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company